港股異動丨醫渡科技一度升超10% 攜手昇騰AI發佈首個醫療領域大模型訓
醫渡科技(2158.HK)盤中一度升超10%,現報3.83港元,總市值40.3億港元。消息上,公司攜手昇騰AI發佈了大模型訓推一體機解決方案,這是醫療健康垂直領域首個軟硬件一體化的大模型解決方案。方案實現開箱可用,內置醫渡科技醫療垂域基礎模型,集成數據處理、模型訓練、微調,場景評測以及外接知識型數據庫等於一身,幫助醫療機構及監管機構更安全易用地打造私有專屬大模型。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.